CD8A and neoplasm: Hoxa10 knockdown substantially inhibited tumor growth, increased cytotoxic CD8+ T cell infiltration, reduced tumor-infiltrating barrier (TIB) density at tumor margins, and decreased immunosuppressive macrophage populations while enhancing macrophage-CD8+ T cell interactions.